UncategorizedThorne unveils creatine campaign featuring Ciara – Longevity.Technology Empower Meds / September 10, 2025
UncategorizedHCW Biologics reports positive non-human primate results for T-cell engager – Longevity.Technology Empower Meds / September 10, 2025
UncategorizedFirst patient dosed in NCI-sponsored trial of cirtuvivint in AML/MDS – Longevity.Technology Empower Meds / September 10, 2025
UncategorizedTolerance Bio and ZipCode Bio form R&D collaboration on thymus therapeutics – Longevity.Technology Empower Meds / September 10, 2025
UncategorizedFirst-in-class oral drug NA-931 shows strong phase 2 obesity results – Longevity.Technology Empower Meds / September 10, 2025
UncategorizedTesting on real human organs can improve drug trial success Empower Meds / September 9, 2025
UncategorizedGoogle launches Calico to tackle aging and disease – Longevity.Technology Empower Meds / September 9, 2025
UncategorizedBioAge valued at $758 mln in Nasdaq debut – Longevity.Technology Empower Meds / September 9, 2025
UncategorizedHaya Therapeutics secures $65m Series A for RNA‑guided precision medicines – Longevity.Technology Empower Meds / September 9, 2025
